Instil Bio, Inc. Common Stock (TIL) Stock
Key stats
- Market cap
- $42.79M
- Price / Earnings ratio
- -1.4x
- EPS (TTM)
- -$4.43
- Volume
- Loading
- 52-week high
- $16.00
- 52-week low
- $5.56
- EPS vs analyst estimate
- +33.2%Q3 FY25 · -$1.75 vs -$2.62
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with TIL
Recent news

5 Biotech Stocks Worth Adding to Your Portfolio Now
5 Biotech Stocks Worth Adding to Your Portfolio Now
TIL

Instil Bio shares slide on discontinuation of lead clinical programs
Instil Bio shares slide on discontinuation of lead clinical programs
TIL

Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
TIL

Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
TIL
Technical indicators
- RSI 14
- 45.02
- MACD 12/26/9
- -0.02
- EMA 9 of MACD
- -0.06
- MACD histogram
- 0.04
- SMA 50
- $6.79
- Price below SMA 50
- EMA 50
- $6.73
- Price below EMA 50
- SMA 200
- $7.66
- Price below SMA 200
- EMA 200
- $7.85
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$2.58 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

5 Biotech Stocks Worth Adding to Your Portfolio Now
5 Biotech Stocks Worth Adding to Your Portfolio Now
TIL

Instil Bio shares slide on discontinuation of lead clinical programs
Instil Bio shares slide on discontinuation of lead clinical programs
TIL

Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
TIL

Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
TIL

Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice
TIL

Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
TIL

Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade
Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade
TIL
About Instil Bio, Inc. Common Stock
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Bronson Crouch | Chairman & CEO | 1973 |
| Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 1969 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 45.02
- MACD 12/26/9
- -0.02
- EMA 9 of MACD
- -0.06
- MACD histogram
- 0.04
- SMA 50
- $6.79
- Price below SMA 50
- EMA 50
- $6.73
- Price below EMA 50
- SMA 200
- $7.66
- Price below SMA 200
- EMA 200
- $7.85
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +4.9 | -21.1 | ||||||||||
| 2022 | -35.9 | -12.1 | +5.2 | -36.6 | -19.9 | -21.0 | +18.7 | +1.2 | -9.0 | -32.0 | -49.4 | -50.0 |
| 2023 | +35.7 | -10.4 | -12.6 | -1.0 | -6.6 | -3.5 | -3.1 | -18.0 | -6.1 | -6.8 | -7.4 | +10.9 |
| 2024 | +51.9 | +1.4 | -9.8 | +2.5 | -0.3 | -6.5 | +18.3 | +12.0 | +383.3 | -48.1 | -6.5 | -30.8 |
| 2025 | +3.0 | -2.4 | -5.0 | -24.5 | +113.7 | -29.7 | +9.4 | +21.5 | -38.9 | -7.6 | -21.7 | -3.8 |
| 2026 | -37.4 | +23.4 | -4.0 | -0.6 | +2.2 | -5.2 | -7.4 | +5.4 | -5.9 | -6.1 | -3.7 |



